Morphic Holding, Inc. 3 SEC Filings

Filed On	Filing
19 Mar 2024	Form 3: Cooper Simon Peter, CMO No securities owned
23 Aug 2021	Form 3: Nanda Nisha, Director Holds 0 shares of No securities beneficially held
29 Apr 2021	Form 3: Gray Susannah, Director Holds 0 shares of No securities beneficially held
03 Dec 2020	Form 3: Edwards Martin, Director Holds 0 shares of No securities beneficially held
08 Apr 2020	Form 3: Schegerin Marc, CFO and COO Holds 2,000 shares of Common Stock
18 Mar 2020	Form 3: Linde Peter, Chief Medical Officer Holds 0 shares of No securities beneficially held
26 Jun 2019	Form 3: Nashat Amir, Director Holds 0 shares of No securities beneficially held
26 Jun 2019	Form 3: Springer Timothy A, Director Holds 600,229 shares of Common Stock
26 Jun 2019	Form 3: Glaxosmithkline Plc, Director
26 Jun 2019	Form 3: Goyal Vikas, Director Holds 0 shares of No securities beneficially held
26 Jun 2019	Form 3: Stampacchia Otello, Director Holds 0 shares of No securities beneficially held
26 Jun 2019	Form 3: Omega Fund V, L.p., 10% owner and 6 others Holds 0 shares of No securities beneficially held
26 Jun 2019	Form 3: Kumar Nilesh, Director Holds 0 shares of No securities beneficially held
26 Jun 2019	Form 3: Slattery Joseph P, Director Holds 0 shares of No securities beneficially held
26 Jun 2019	Form 3: Dalton Barbara, Director Holds 0 shares of No securities beneficially held
26 Jun 2019	Form 3: Christensen Gustav, Director Holds 22,294 shares of Common Stock
26 Jun 2019	Form 3: Bischofberger Norbert W, Director Holds 0 shares of No securities beneficially held
26 Jun 2019	Form 3: DeVaul William, General Counsel and Secretary Holds 0 shares of No securities beneficially held
26 Jun 2019	Form 3: Lugovskoy Alexey, Chief Development Officer Holds 130,748 shares of Common Stock
26 Jun 2019	Form 3: Rogers Bruce, Chief Scientific Officer Holds 195,819 shares of Common Stock

Comments